Hidradenitis suppurativa trials in South Korea

2 of 3 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea

  Where

  Seoul

  Age

  6 years to 100 years

  People

  76

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07243782
• No phaseTaking people
  A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa

  Where

  Seoul

  Age

  12 years and over

  People

  2,795 worldwide

  Run by

  AbbVie

  See details and how to joinNCT07136467